chr10-49648597-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_020549.5(CHAT):​c.1372C>T​(p.Leu458Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00511 in 1,611,882 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0037 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0053 ( 26 hom. )

Consequence

CHAT
NM_020549.5 missense

Scores

2
10
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 7.91

Publications

7 publications found
Variant links:
Genes affected
CHAT (HGNC:1912): (choline O-acetyltransferase) This gene encodes an enzyme which catalyzes the biosynthesis of the neurotransmitter acetylcholine. This gene product is a characteristic feature of cholinergic neurons, and changes in these neurons may explain some of the symptoms of Alzheimer's disease. Polymorphisms in this gene have been associated with Alzheimer's disease and mild cognitive impairment. Mutations in this gene are associated with congenital myasthenic syndrome associated with episodic apnea. Multiple transcript variants encoding different isoforms have been found for this gene, and some of these variants have been shown to encode more than one isoform. [provided by RefSeq, May 2010]
CHAT Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 6
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013102263).
BP6
Variant 10-49648597-C-T is Benign according to our data. Variant chr10-49648597-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 199158.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00367 (559/152292) while in subpopulation NFE AF = 0.00523 (356/68028). AF 95% confidence interval is 0.00478. There are 3 homozygotes in GnomAd4. There are 302 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHATNM_020549.5 linkc.1372C>T p.Leu458Phe missense_variant Exon 9 of 15 ENST00000337653.7 NP_065574.4 P28329-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHATENST00000337653.7 linkc.1372C>T p.Leu458Phe missense_variant Exon 9 of 15 1 NM_020549.5 ENSP00000337103.2 P28329-1

Frequencies

GnomAD3 genomes
AF:
0.00367
AC:
559
AN:
152174
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00113
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000981
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0130
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00523
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00388
AC:
967
AN:
249232
AF XY:
0.00372
show subpopulations
Gnomad AFR exome
AF:
0.000808
Gnomad AMR exome
AF:
0.000958
Gnomad ASJ exome
AF:
0.0000995
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0150
Gnomad NFE exome
AF:
0.00505
Gnomad OTH exome
AF:
0.00477
GnomAD4 exome
AF:
0.00527
AC:
7685
AN:
1459590
Hom.:
26
Cov.:
31
AF XY:
0.00504
AC XY:
3659
AN XY:
726158
show subpopulations
African (AFR)
AF:
0.000598
AC:
20
AN:
33444
American (AMR)
AF:
0.000917
AC:
41
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39680
South Asian (SAS)
AF:
0.000139
AC:
12
AN:
86026
European-Finnish (FIN)
AF:
0.0131
AC:
696
AN:
53288
Middle Eastern (MID)
AF:
0.00174
AC:
10
AN:
5760
European-Non Finnish (NFE)
AF:
0.00594
AC:
6597
AN:
1110256
Other (OTH)
AF:
0.00507
AC:
306
AN:
60314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
342
684
1025
1367
1709
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
256
512
768
1024
1280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00367
AC:
559
AN:
152292
Hom.:
3
Cov.:
32
AF XY:
0.00406
AC XY:
302
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.00113
AC:
47
AN:
41556
American (AMR)
AF:
0.000980
AC:
15
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.0130
AC:
138
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00523
AC:
356
AN:
68028
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
34
68
103
137
171
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00474
Hom.:
9
Bravo
AF:
0.00271
TwinsUK
AF:
0.00647
AC:
24
ALSPAC
AF:
0.00467
AC:
18
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.00407
AC:
35
ExAC
AF:
0.00365
AC:
443
EpiCase
AF:
0.00442
EpiControl
AF:
0.00541

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CHAT: BS2 -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:2
Nov 23, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial infantile myasthenia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.30
BayesDel_addAF
Uncertain
0.074
D
BayesDel_noAF
Pathogenic
0.34
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.44
.;.;.;T;.;.
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.89
.;.;D;D;D;D
MetaRNN
Benign
0.013
T;T;T;T;T;T
MetaSVM
Uncertain
0.57
D
MutationAssessor
Uncertain
2.4
.;.;.;M;.;.
PhyloP100
7.9
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-2.2
N;N;N;N;N;.
REVEL
Pathogenic
0.83
Sift
Benign
0.070
T;T;T;T;T;.
Sift4G
Benign
0.12
T;T;T;T;T;.
Polyphen
1.0
.;.;.;D;.;.
Vest4
0.77
MVP
0.97
MPC
0.93
ClinPred
0.014
T
GERP RS
5.0
Varity_R
0.69
gMVP
0.67
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76014951; hg19: chr10-50856643; API